Stroke Prevention Drug: Proven Benefits for Patients
Stroke prevention drug news highlights Bayer’s first global approval in China, promising enhanced treatment options for patients.
Stroke prevention drug news highlights Bayer’s first global approval in China, promising enhanced treatment options for patients.
Rare disease portfolio growth is crucial for pharma companies. Explore Shionogi’s $2B acquisition of IntraBio and its implications.
